Vista normal Vista MARC Vista ISBD

Behavioral Pharmacology of Neuropeptides: Oxytocin [electronic resource] / edited by Rene Hurlemann, Valery Grinevich.

Colaborador(es): Hurlemann, Rene [editor.] | Grinevich, Valery [editor.] | SpringerLink (Online service)Tipo de material: Texto

TextoSeries Current Topics in Behavioral Neurosciences ; 35Editor: Cham : Springer International Publishing : Imprint: Springer, 2018Edición: 1st ed. 2018Descripción: IX, 593 p. 130 illus., 30 illus. in color. online resourceTipo de contenido: text Tipo de medio: computer Tipo de portador: online resourceISBN: 9783319637396Tema(s): Neurosciences | Psychiatry | Behavioral sciences | Endocrinology | Neurosciences | Psychiatry | Behavioral Sciences | EndocrinologyFormatos físicos adicionales: Printed edition:: Sin título; Printed edition:: Sin título; Printed edition:: Sin títuloClasificación CDD: 612.8 Clasificación LoC:RC321-580Recursos en línea: Libro electrónico Texto

Contenidos:

Preface -- Part 1 Human Research -- Oxytocin Administration in Humans. Oxytocin & Human Social Perception. Oxytocin & Human Social Cognition. Oxytocin & Human Pair Bonding. Oxytocin & Human Parenting. Oxytocin & Autism Spectrum Disorders. Oxytocin & Anxiety Disorders. Oxytocin & Borderline Personality Disorder. Oxytocin & Schizophrenia Spectrum Disorders. Oxytocin & Prader-Willi Syndrome. Translating oxytocin research into therapeutics: a precision medicine approach -- Part 2 Animal Research -- Oxytocin Receptor Signaling. Oxytocin & Steroid Action. Oxytocin & Olfaction. Oxytocin & Social Behavior of Primates. Oxytocin & Parental Behavior. Oxytocin & Pain. Oxytocin & Alcohol Abuse. Oxytocin & Autism Spectrum Disorders. Genetics & Early Life Development of the oxytocin system. Oxytocin, Pair-Bonding and Partner Loss. Oxytocin & Cortical Function.

En: Springer Nature eBookResumen: This volume collects cutting-edge expert reviews in the oxytocin field and will be of interest to a broad scientific audience ranging from social neuroscience to clinical psychiatry. The role of the neuropeptide oxytocin in social behaviors is one of the earliest and most significant discoveries in social neuroscience. Influential studies in animal models have delineated many of the neural circuits and genetic components that underlie these behaviors. These discoveries have inspired researchers to investigate the effects of oxytocin on brain and behavior in humans and its potential relevance as a treatment for psychiatric disorders including borderline personality disorder and autism and schizophrenia spectrum disorders. In fact, there is no established social psychopharmacology in Psychiatry, and oxytocin can be seen as the first endogenous agent specifically addressing social-cognitive impairment in psychiatric disorders, with animal research suggesting that it could be especially efficient in the early postnatal period. From a human perspective, it is crucial to understand more precisely who can benefit from potential oxytocin-related treatments, which outcome measures will best represent their effects, how they should be administered, and what brain mechanisms are likely involved in mediating their effects. This type of "precision medicine" approach is in line with the research domain criteria defined by the U.S. National Institute of Mental Health.

Existencias ( 1 )
Notas de título ( 4 )

Existencias
Tipo de ítem	Biblioteca actual	Colección	Signatura	Copia número	Estado	Fecha de vencimiento	Código de barras
Libro Electrónico	Biblioteca Electrónica	Colección de Libros Electrónicos		1	No para préstamo

Acceso multiusuario

This volume collects cutting-edge expert reviews in the oxytocin field and will be of interest to a broad scientific audience ranging from social neuroscience to clinical psychiatry. The role of the neuropeptide oxytocin in social behaviors is one of the earliest and most significant discoveries in social neuroscience. Influential studies in animal models have delineated many of the neural circuits and genetic components that underlie these behaviors. These discoveries have inspired researchers to investigate the effects of oxytocin on brain and behavior in humans and its potential relevance as a treatment for psychiatric disorders including borderline personality disorder and autism and schizophrenia spectrum disorders. In fact, there is no established social psychopharmacology in Psychiatry, and oxytocin can be seen as the first endogenous agent specifically addressing social-cognitive impairment in psychiatric disorders, with animal research suggesting that it could be especially efficient in the early postnatal period. From a human perspective, it is crucial to understand more precisely who can benefit from potential oxytocin-related treatments, which outcome measures will best represent their effects, how they should be administered, and what brain mechanisms are likely involved in mediating their effects. This type of "precision medicine" approach is in line with the research domain criteria defined by the U.S. National Institute of Mental Health.

UABC ; Temporal ; 01/01/2021-12/31/2023.